What is the improvement in NYHA class reported in trials of Intravenous Iron in Chronic Heart Failure?
Data on improvement in NYHA has only been extracted where quality of life data is not reported in a trial. The quality of the evidence is stated as VERY LOW due to risk of bias, indirectness, and imprecision, and the relative effect is stated as ranging from 144 fewer to 1000 more.